| Title |
Author |
Type |
Date |
Words |
| PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites. |
|
|
May 23, 2022 |
722 |
| Thermo Fisher Scientific, LabShares Partner to Support Emerging Boston Biotechs. |
|
|
May 20, 2022 |
193 |
| Trinity Biotech announces CE Mark for 10-minute COVID-19 antigen test. |
|
|
May 20, 2022 |
171 |
| Adverum Biotechnologies presents research piepline data at ASGCT. |
|
|
May 19, 2022 |
314 |
| Brickell Biotech doses first subject in Phase 1 study of BBI-01. |
|
|
May 19, 2022 |
205 |
| PolyU's Pioneering Technologies in AI, Materials Science and Biotechnology Awarded at TechConnect 2022 Innovation Awards. |
|
|
May 19, 2022 |
622 |
| Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. |
|
|
May 19, 2022 |
169 |
| Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. |
|
|
May 19, 2022 |
182 |
| IO Biotech announces initiation of Phase 3 trial of IOB102-IOB103, KEYTRUDA. |
|
|
May 18, 2022 |
215 |
| Precision BioSciences publishes data from in vivo gene editing program. |
|
|
May 18, 2022 |
292 |
| Purple Biotech announces initiation of Phase 2 study for CM24. |
|
|
May 18, 2022 |
228 |
| 'Pak-Turk-Kazakh Youth Forum on Biotech' to be held in Sept. |
|
|
May 16, 2022 |
470 |
| Gulf Biotech to manufacture injectable drugs. |
|
|
May 12, 2022 |
290 |
| Brickell Biotech reports Q1 EPS (8c), consensus (6c). |
|
Financial report |
May 12, 2022 |
217 |
| 'Pak-Turk-Kazakh Youth Forum on Biotech' to be held in September. |
|
|
May 11, 2022 |
470 |
| PDS Biotechnology reports Q1 EPS (32c), consensus (22c). |
|
Financial report |
May 11, 2022 |
180 |
| Evaxion Biotech reports Q1 EPS (25c), consensus (33c). |
|
Financial report |
May 11, 2022 |
174 |
| Iroquois: PharmaCyte Biotech has failed to create meaningful value for holders. |
|
|
May 11, 2022 |
289 |
| Moleculin Biotech receives approval from UK MHRA for Phase 1a study of WP1122. |
|
|
May 10, 2022 |
195 |
| SQZ Biotechnologies to Make First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with Stemcell Technologies on Research-Use-Only System to Fuel Preclinical Research. |
|
Clinical report |
May 10, 2022 |
507 |
| Unity Biotechnology reports Q1 EPS (28c), consensus (26c). |
|
Financial report |
May 10, 2022 |
173 |
| Moleculin Biotech's Phase 1/2 Annamycin study in AML allowed to proceed. |
|
|
May 5, 2022 |
163 |
| Unity Biotechnology presents on UBX1325 at ARVO 2022. |
|
|
May 5, 2022 |
322 |
| Vir Biotechnology reports Q1 EPS $3.85, consensus $3.78. |
|
Financial report |
May 5, 2022 |
222 |
| Agastiya Biotech and Vopec Pharmaceuticals' AB001 granted US FDA Orphan Drug Designation. |
|
|
May 4, 2022 |
196 |
| Agastiya Biotech and Vopec Pharmaceuticals' AB001 granted US FDA Orphan Drug Designation. |
|
|
May 4, 2022 |
197 |
| SIU's $13M interdisciplinary fermentation, food and biotech research hub advances. |
TIM CROSBY SIU News Service |
|
May 4, 2022 |
1141 |
| Virica Biotech Forges Collaboration with the Government of Canada. |
|
|
May 3, 2022 |
273 |
| Orgenesis announces MIDA Biotech received approval for EUR4M grant. |
|
|
May 3, 2022 |
211 |
| Plant-Based Bimetallic Silver-Zinc Oxide Nanoparticles: A Comprehensive Perspective of Synthesis, Biomedical Applications, and Future Trends. |
Ehsan, Maria; Waheed, Abdul; Ullah, Abd; Kazmi, Abeer; Ali, Amir; Raja, Naveed Iqbal; Mashwani, Zia- |
Report |
Apr 30, 2022 |
14424 |
| Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: Integrated bioinformatic analysis. |
Ren, Yi; Labinsky, Hannah; Palmowski, Andriko; Backer, Henrik; Muller, Michael; Kienzle, Arne |
Report |
Apr 30, 2022 |
7377 |
| Vir Biotechnology announces new data from MARCH hepatitis B trial. |
|
|
Apr 27, 2022 |
412 |
| MAIA biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Hepatocellular Carcinoma. |
|
|
Apr 26, 2022 |
289 |
| ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine Using Proprietary B-Tech Vector Platform. |
|
|
Apr 26, 2022 |
809 |
| £2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA; Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS. |
By, Sam Volpe |
|
Apr 26, 2022 |
696 |
| Human genome sequence recorded in Bahrain. |
|
|
Apr 25, 2022 |
478 |
| First complete sequence of human genome sequence recorded in Bahrain. |
|
|
Apr 24, 2022 |
463 |
| Biotechnology Remains Nigeria's Engine-room for Food Security, Zero Hunger'. |
|
|
Apr 22, 2022 |
386 |
| Moleculin Biotech receives IND clearance for Phase 1 study of glioma candidate. |
|
|
Apr 21, 2022 |
186 |
| Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T. |
|
|
Apr 21, 2022 |
370 |
| Fighting hunger with biotech food. |
|
|
Apr 21, 2022 |
909 |
| Unity Biotechnology doses first patient in ENVISION study of UBX1325. |
|
|
Apr 19, 2022 |
180 |
| PharmaCyte Biotech announces results from pancreatic cancer clinical trial. |
|
|
Apr 19, 2022 |
228 |
| Gulf Biotech to manufacture injectable drugs in Bahrain. |
|
|
Apr 17, 2022 |
315 |
| NHRA licenses Gulf Biotech to manufacture injectable drugs. |
|
|
Apr 16, 2022 |
297 |
| Evelo Biosciences updates guidance on clinical inflammation programs. |
|
|
Apr 14, 2022 |
200 |
| Moleculin Biotech announces corporate rebranding, launch of new website. |
|
Website overview |
Apr 14, 2022 |
159 |
| SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo. |
|
|
Apr 14, 2022 |
698 |
| Purigen Biosystems Expands Commercial Presence in European Union with GC biotech Distribution Agreement. |
|
|
Apr 14, 2022 |
272 |
| Nigeria, Cuba To Deepen Ties On Biotechnology Development. |
|
|
Apr 14, 2022 |
218 |
| Qatar, Sinovac Biotech donate 75K Covid-19 jabs to PH. |
|
|
Apr 13, 2022 |
297 |
| Portage Biotech highlights data presented on PORT-5 at AACR 2022. |
|
|
Apr 13, 2022 |
207 |
| Daewoong Pharmaceutical and HanAll Biopharma expand open collaboration strategy by investing in Turn Biotechnologies. |
|
|
Apr 12, 2022 |
188 |
| Daewoong Pharmaceutical and HanAll Biopharma expand open collaboration strategy by investing in Turn Biotechnologies. |
|
|
Apr 12, 2022 |
187 |
| Unity Biotechnology completes enrollment in BEHOLD study. |
|
|
Apr 12, 2022 |
172 |
| Ansa Biotechnologies Closes Oversubscribed USD 68m Series A Financing to Power the Next Era of DNA-Enabled Industries. |
|
|
Apr 12, 2022 |
558 |
| Purple Biotech presents interim Phase 1b study results for CM24. |
|
|
Apr 11, 2022 |
318 |
| Trinity Biotech enters $45M strategic investment, partnership with MiCo. |
|
|
Apr 11, 2022 |
680 |
| Biotech breakthrough in virus vaccines. |
|
|
Apr 11, 2022 |
253 |
| Nigeria, Cuba To Deepen Ties On Biotechnology Development. |
|
|
Apr 11, 2022 |
220 |
| PDS Biotechnology reports inducement grants under Nasdaq listing rule. |
|
|
Apr 8, 2022 |
169 |
| Moleculin Biotech to present preclinical annamycin data at AACR. |
|
|
Apr 8, 2022 |
248 |
| IO Biotech presents new data from MM1636 Phase 1/2 trial. |
|
|
Apr 8, 2022 |
270 |
| VM biotechnology Awarded USD 1.6m Phase II SBIR Grant to Study AVM0703's Potential to Reverse Type 1 Diabetes. |
|
|
Apr 6, 2022 |
627 |
| Ghanaian Delegation To Understudy Nigeria's Regulatory Infrastructure, Policies In Biotechnology. |
|
|
Apr 6, 2022 |
614 |
| Ghanaian Delegation To Understudy Nigeria's Regulatory Infrastructure, Policies In Biotechnology. |
|
|
Apr 5, 2022 |
610 |
| Ghana Applauds Nigeria's Biotechnology Success Story. |
|
|
Apr 5, 2022 |
478 |
| Roche, world's biggest biotech company, officially opens new site in Cape Town. |
|
|
Apr 5, 2022 |
390 |
| WHO suspends supply of Bharat Biotech's COVID-19 through UN agencies. |
|
|
Apr 4, 2022 |
226 |
| WHO suspends supply of Bharat Biotech's COVID-19 through UN agencies. |
|
|
Apr 4, 2022 |
227 |
| Dye Ligand Affinity Nanoparticles for the Depletion of Biomolecules in Proteomics. |
Kusat, Kevser |
|
Apr 1, 2022 |
3405 |
| Portage Biotech provides update on clinical-stage, development programs. |
|
|
Mar 31, 2022 |
430 |
| United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. |
|
|
Mar 30, 2022 |
337 |
| United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. |
|
|
Mar 30, 2022 |
320 |
| Shanghai Henlius Biotech's HANSIZHUANG receives Chinese regulatory approval. |
|
|
Mar 28, 2022 |
238 |
| Shanghai Henlius Biotech's HANSIZHUANG receives Chinese regulatory approval. |
|
|
Mar 28, 2022 |
237 |
| Fortress Biotech reports 2021 EPS 25c, consensus (26c). |
|
Financial report |
Mar 28, 2022 |
426 |
| Krystal Biotech announces publication of Phase 1, 2 trial data of B-VEC. |
|
|
Mar 28, 2022 |
264 |
| Vir Biotechnology, GlaxoSmithKline: FDA amends EUA Fact Sheet for sotrovimab. |
|
|
Mar 25, 2022 |
156 |
| Vir Biotechnology gives additional information on sotrovimab EUA amendment. |
|
|
Mar 25, 2022 |
228 |
| Evaxion Biotech reports Q4 EPS (39c), consensus (29c). |
|
Financial report |
Mar 22, 2022 |
187 |
| Edesa Biotech announces $10M registered direct offering. |
|
|
Mar 22, 2022 |
179 |
| Lixte Biotechnology announces new findings on OCCC patients. |
|
|
Mar 22, 2022 |
190 |
| PharmaCyte Biotech completes 24-month CypCaps product stability study. |
|
|
Mar 22, 2022 |
226 |
| Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. |
|
|
Mar 21, 2022 |
249 |
| Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. |
|
|
Mar 21, 2022 |
248 |
| SQZ Biotechnologies Announces USD 2m Grant from the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson's Disease. |
|
|
Mar 21, 2022 |
331 |
| Founders of Taiwan biotech firm sentenced for stealing trade secrets from Genentech. |
|
|
Mar 17, 2022 |
326 |
| Protagonist Therapeutics earns $25M milestone payment from Janssen Biotech. |
|
|
Mar 16, 2022 |
157 |
| Sana Biotechnology reports Q4 EPS (65c) vs ($2.98) last year. |
|
Financial report |
Mar 16, 2022 |
164 |
| MAIA biotechnology Raises USD 2.4m in Equity Financing. |
|
|
Mar 16, 2022 |
384 |
| SQZ Biotechnologies reports FY21 EPS ($2.49), consensus ($2.75). |
|
Financial report |
Mar 16, 2022 |
166 |
| PHL files updated biotechnology rules covering beneficial GMOs. |
|
|
Mar 15, 2022 |
532 |
| Krystal Biotech enters binding term sheet for settlement with PeriphaGen. |
|
|
Mar 15, 2022 |
196 |
| Brickell Biotech reports Q4 EPS (6c), consensus (8c). |
|
Financial report |
Mar 15, 2022 |
164 |
| PDS Biotechnology says NCi achieves enrollment objective in Phase 2 trial. |
|
|
Mar 15, 2022 |
209 |
| Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System. |
|
|
Mar 14, 2022 |
551 |
| US Biotech InSitu Biologics Joins the in5 Incubator in UAE. |
|
|
Mar 11, 2022 |
207 |
| Vladimir Putin's secret stash of chemical weapons -including anthrax and Ebola; The massive centre, known as Vector, in Siberia is believed to house deadly diseases such as small pox and anthrax in the Research on Virology and Biotechnology. |
By, Chris Hughes & Antony Thrower |
|
Mar 11, 2022 |
526 |
| Substantial training course on recent trends in biotechnology gets underway at SU. |
|
|
Mar 8, 2022 |
818 |
| Substantial Training Course On Recent Trends In Biotechnology Gets Underway At SU. |
|
|
Mar 8, 2022 |
399 |
| Substantial training course on recent trends in biotechnology gets underway at SU. |
|
|
Mar 8, 2022 |
818 |
| NUMS' scientist makes breakthrough by developing much cheaper source of Omega-3, through biotechnology. |
|
|
Mar 7, 2022 |
393 |
| NUMS' scientist makes breakthrough by developing much cheaper source of Omega-3 using biotechnology. |
|
|
Mar 6, 2022 |
392 |
| ARISTA Biotech Plans Hong Kong Cleanroom Production Plant for COVID-19 Rapid Test Kits; Donates 15,00. |
|
|
Feb 17, 2022 |
417 |
| US FDA Places Clinical Hold of Legend Biotech Phase 1 Clinical Trial for LB1901. |
|
|
Feb 15, 2022 |
239 |
| Pluslife Biotech unveils first handheld Covid-19 Nucleic Acid Test in Hong Kong. |
|
|
Feb 14, 2022 |
251 |
| Pluslife Biotech unveils first handheld Covid-19 Nucleic Acid Test in Hong Kong. |
|
|
Feb 14, 2022 |
252 |
| Legend Biotech Achieves Milestone Payments in BCMA CAR-T Collaboration with Janssen. |
|
|
Feb 14, 2022 |
378 |
| EdiGene, Arbor Biotechnologies Ink License for CRISPR Technology. |
|
|
Feb 9, 2022 |
286 |
| SAN Group to set up new green biotechnology facility in Rakez. |
Jason Saundalkar |
|
Feb 9, 2022 |
399 |
| SAN Group to set up new green biotechnology facility in Rakez. |
Jason Saundalkar |
|
Feb 9, 2022 |
420 |
| Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
188 |
| Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
186 |
| Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
187 |
| Austrian group to build green biotechnology facility in RAK. |
|
|
Feb 8, 2022 |
417 |
| Algae the key as KAUST seaweed biotech aims to boost Kingdom's fisheries. |
George Charles Darley |
|
Feb 8, 2022 |
641 |
| SAN Group to set up $3m green biotechnology unit in Ras Al Khaimah. |
|
|
Feb 8, 2022 |
403 |
| Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
164 |
| Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
165 |
| Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
163 |
| S. African biotech firm makes Africa's first mRNA vaccine. |
|
|
Feb 4, 2022 |
576 |
| Acticor Biotech announces encouraging results from Phase 2 GARDEN study in COVID-19 ARDS. |
|
Clinical report |
Feb 3, 2022 |
257 |
| Acticor Biotech announces encouraging results from Phase 2 GARDEN study in COVID-19 ARDS. |
|
Clinical report |
Feb 3, 2022 |
258 |
| Minerva Biotechnologies Opens 1st-In-Human Phase I/II Trial of a MUC1*Targeting CAR T for Metastatic Breast Cancers at city of Hope. |
|
|
Feb 2, 2022 |
214 |
| Abcam Collaborates with Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications. |
|
|
Feb 1, 2022 |
455 |
| US Food and Drug Administration grants Nanjing Bioheng Biotech's CTB001 Orphan Drug Designation. |
|
|
Jan 31, 2022 |
163 |
| US Food and Drug Administration grants Nanjing Bioheng Biotech's CTB001 Orphan Drug Designation. |
|
|
Jan 31, 2022 |
162 |
| Covaxin now a universal COVID vaccine for adults, children: Bharat Biotech. |
|
|
Jan 29, 2022 |
311 |
| Cellino Biotech Closes USD 80m Series A Financing Led by Bayer. |
|
|
Jan 26, 2022 |
286 |
| SQZ Biotechnologies Receives FDA Clearance of Investigational New Drug Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors. |
|
|
Jan 24, 2022 |
716 |
| Virica Biotech Forges R and D Partnership with Oxford Biomedica to Improve the Manufacturing of Lentiviral Vector Gene Therapies Using Viral Sensitizers. |
|
|
Jan 24, 2022 |
352 |
| 'Wonder pill' breakthrough containing combined Covid and flu vaccines; Brit biotech firm iosBio has made a breakthrough in the making of a combined flu and Covid vaccine pill that would be a massive boost in tackling the respiratory viruses. |
By, Tim Hanlon |
|
Jan 22, 2022 |
519 |
| Parse Biosciences Forges Partnership with Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region. |
|
|
Jan 20, 2022 |
371 |
| Novak Djokovic owns 80% stake in biotech firm aiming to develop Covid treatment; Novak Djokovic has been strong in his stance against the Covid vaccine, and now it has emerged that he holds a majority stake at a Danish biotech firm aiming to develop a treatment against the virus. |
By, Liam Llewellyn |
|
Jan 19, 2022 |
335 |
| Nashville Biosciences, Illumina Ink Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research and Development. |
|
|
Jan 14, 2022 |
522 |
| Bharat Biotech's Covaxin COVID-19 booster shot neutralises Omicron variant. |
|
|
Jan 12, 2022 |
154 |
| Bharat Biotech's Covaxin COVID-19 booster shot neutralises Omicron variant. |
|
|
Jan 12, 2022 |
155 |
| Massive PS730m cancer drug deal for biotech firm. |
COREENA FORD Business Reporter coreena.ford@reachplc.com @scoopford |
|
Jan 11, 2022 |
399 |
| Stronger policy on agri-biotech pushed for progressive, resilient food system. |
|
|
Jan 9, 2022 |
579 |
| FDA Grants ILiAD Biotechnologies Fast Track Designation for Next Generation Pertussis Vaccine BPZE1. |
|
|
Jan 3, 2022 |
679 |
| The Role of Policy in Supporting a Globally Diverse Bio-Economy That Mitigates Climate Change and Food Insecurity. |
Zilberman, David; Wesseler, Justus |
|
Jan 1, 2022 |
2048 |
| Turkey set to build vaccine, biotech hub in capital Ankara. |
|
|
Dec 31, 2021 |
405 |
| Cyrus Biotechnology's COVID Therapeutic Lead, ACE2.v2.4, Strongly Binds and Neutralizes SARS-CoV-2 Omicron Variant Potentially Providing Long Term Protection. |
|
|
Dec 30, 2021 |
416 |
| Biotech firm moves into city science park; helping to develop new vaccines. |
DANIEL CLARK Daniel.Clark@reachplc.com @HEDANIELCLARK |
|
Dec 29, 2021 |
453 |
| Accutar Biotechnology Receives FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer. |
|
|
Dec 27, 2021 |
215 |
| Screening and Functional Verification of Selectable Marker Genes for Cordyceps militaris. |
Lou, Haiwei; Zhao, Yu; Zhao, Renyong; Ye, Zhiwei; Lin, Junfang; Guo, Liqiong |
|
Dec 27, 2021 |
5596 |
| Taysha added to the ICE biotechnology index. |
|
|
Dec 24, 2021 |
165 |
| Taysha added to the ICE biotechnology index. |
|
|
Dec 24, 2021 |
164 |
| US blacklists Chinese biotech firms over rights abuses. |
|
|
Dec 24, 2021 |
224 |
| Minister stresses use of biotechnology to boost agri production. |
|
|
Dec 24, 2021 |
212 |
| The New Era Biotechnology deepens cooperation between China and Belarus. |
|
|
Dec 22, 2021 |
299 |
| Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration. |
|
|
Dec 22, 2021 |
692 |
| India's Bharat Biotech applies to heath regulator for late-stage trial of intranasal COVID-19 vaccine booster. |
|
|
Dec 20, 2021 |
191 |
| India's Bharat Biotech applies to heath regulator for late-stage trial of intranasal COVID-19 vaccine booster. |
|
|
Dec 20, 2021 |
192 |
| Seychelles receives 40,000 Pfizer-Biotech COVID-19 vaccines from U.S. government. |
|
|
Dec 18, 2021 |
502 |
| ARISTA Biotech Confirms Antigen Test Effectiveness Against Omicron and other COVID variants. |
|
|
Dec 15, 2021 |
655 |
| SQZ Biotechnologies Data Shows Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient. |
|
|
Dec 9, 2021 |
539 |
| Boston Properties's JV signs full-building lease with biotech firm at 751 Gateway in San Francisco. |
|
|
Dec 7, 2021 |
244 |
| ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
171 |
| ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
173 |
| ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
172 |
| MingMed Biotechnology's Investigational New Drug application for PRJ1-3024 receives US FDA approval. |
|
|
Dec 3, 2021 |
211 |
| MingMed Biotechnology's Investigational New Drug application for PRJ1-3024 receives US FDA approval. |
|
|
Dec 3, 2021 |
212 |
| SQZ Biotechnologies Accepted by Roche Accelerator in China. |
|
|
Dec 2, 2021 |
267 |
| Biotech firm has relocated to Deeside. |
|
|
Dec 1, 2021 |
228 |
| Premas Biotech and Oravax Medical to initiate testing of oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus. |
|
|
Dec 1, 2021 |
254 |
| Premas Biotech and Oravax Medical to initiate testing of oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus. |
|
|
Dec 1, 2021 |
255 |
| Keeping Chinese Rinding Out of U.S. Biotech. |
Du, Eric |
|
Dec 1, 2021 |
1937 |
| In silico Analysis of Virulence, Resistance Genes and Phylogeny of Helicobacter pylori Strains from Different Continents/Farkli Kitalardaki Helicobacter pylori Suslarinin Virulans, Direnc Genleri ve Filogenisinin in silico Analizi. |
Demirci, Mehmet; Unlu, Ozge; Kocazeybek, Bekir S. |
|
Dec 1, 2021 |
5154 |
| Pharmaniaga: Sinovac Biotech closely monitoring clinical study progress of Covid-19 Omicron variant. |
|
Clinical report |
Nov 30, 2021 |
258 |
| Sartorius Stedim Biotech to expand French facilities capacities for production, innovation, and storage. |
|
|
Nov 29, 2021 |
200 |
| Sartorius Stedim Biotech to expand French facilities capacities for production, innovation, and storage. |
|
|
Nov 29, 2021 |
201 |
| N1.6bn Budget For NABDA Grossly Inadequate - Prof. Mustapha. |
|
|
Nov 28, 2021 |
1864 |
| NBMA To Ensure Equity In Application Of Modern Biotech. |
|
|
Nov 28, 2021 |
428 |
| Study suggests Bharat Biotech's COVID-19 vaccine 50% effective at height of India's infections. |
|
|
Nov 24, 2021 |
208 |
| Study suggests Bharat Biotech's COVID-19 vaccine 50% effective at height of India's infections. |
|
|
Nov 24, 2021 |
207 |
| Food security: AATF scores Nigeria high in biotech deployment, adoption. |
|
|
Nov 23, 2021 |
469 |
| Gilead Exercises Options to Three Arcus Biosciences Clinical-stage Programs and Adds Research Collaboration. |
|
|
Nov 22, 2021 |
656 |
| ImStem Biotechnology doses first United States multiple sclerosis patient with IMS001. |
|
|
Nov 19, 2021 |
194 |
| ImStem Biotechnology doses first United States multiple sclerosis patient with IMS001. |
|
|
Nov 19, 2021 |
195 |
| The New Era Biotechnology deepens cooperation between China and Belarus in the CBIP. |
|
|
Nov 19, 2021 |
278 |
| Greenleaf Biotech Took Me Out Of Nigeria For The First Time - Zakari. |
|
|
Nov 12, 2021 |
1292 |
| Who's Who: Abdulrahman A. Alolayan, CEO of Dammam Biotech Valley. |
Arab News |
|
Nov 8, 2021 |
330 |
| Nigeria, Cuba To Deepen Relationship In Biotechnology Development. |
|
|
Nov 8, 2021 |
266 |
| Nigeria, Cuba To Strengthen Cooperation On Biotechnology Development. |
|
|
Nov 8, 2021 |
258 |
| Puma Biotechnology reports Q3 adjusted EPS (99c), consensus (31c). |
|
Financial report |
Nov 4, 2021 |
162 |
| Adverum Biotechnologies reports Q3 EPS (39c), consensus (37c). |
|
Financial report |
Nov 4, 2021 |
179 |
| Zimbabwe to vaccinate 16 and 17 year-olds with Sinovac Biotech's COVID-19 vaccine. |
|
|
Nov 2, 2021 |
166 |
| Zimbabwe to vaccinate 16 and 17 year-olds with Sinovac Biotech's COVID-19 vaccine. |
|
|
Nov 2, 2021 |
165 |
| Nautilus Biotechnology, Abcam partner for exploration of the proteome. |
|
|
Nov 2, 2021 |
156 |
| Legend Biotech announces extension of PDUFA date for Cilta-Cel. |
|
|
Nov 1, 2021 |
187 |
| Life sciences raised $1 billion in capital last year, and we know why: Covid gave several biotech companies a boost. |
Mumford, Jacqueline |
|
Nov 1, 2021 |
1663 |
| Krystal Biotech announces completion of the GEM-3 Phase 3 study evaluating B-VEC. |
|
|
Oct 26, 2021 |
170 |
| Evaxion Biotech announces filing of registration statement in the the U.S. |
|
|
Oct 26, 2021 |
173 |
| Purple Biotech expands collaboration to evaluate NT219, immuno-oncology drugs. |
|
|
Oct 26, 2021 |
157 |
| Matica Biotechnology signs joint research agreement with Sartorius. |
|
|
Oct 19, 2021 |
202 |
| Matica Biotechnology signs joint research agreement with Sartorius. |
|
|
Oct 19, 2021 |
201 |
| PerkinElmer, Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis. |
|
|
Oct 19, 2021 |
364 |
| Avidity Biosciences lead program AOC 1001 granted Fast Track Designation by FDA. |
|
|
Oct 18, 2021 |
165 |
| Twist Bioscience, the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research. |
|
|
Oct 18, 2021 |
334 |
| Fortress Biotech, Cyprium Therapeutics announce 'positive' CUTX101 clinical data. |
|
|
Oct 13, 2021 |
187 |
| ViA?t Nam to further develop biotechnology industry by 2030. |
|
|
Oct 13, 2021 |
182 |
| ViA?t Nam-RoK jointly-founded institute promotes R&D in biotechnology. |
|
|
Oct 8, 2021 |
449 |
| Curative Biotechnology licenses IMT504 from Mid-Atlantic BioTherapeutics for development of COVID-19 Vaccine. |
|
|
Oct 8, 2021 |
188 |
| Curative Biotechnology licenses IMT504 from Mid-Atlantic BioTherapeutics for development of COVID-19 Vaccine. |
|
|
Oct 8, 2021 |
187 |
| Fortress Biotech, Cyprium Therapeutics announce clinical data for CUTX-101. |
|
|
Oct 8, 2021 |
412 |
| Brickell Biotech reports 'positive' results from Phase 3 Cardigan I, II studies. |
|
|
Oct 7, 2021 |
284 |
| Unity Biotechnology announces 12-week data from Phase 1 trial of UBX1325. |
|
|
Oct 5, 2021 |
402 |
| Biotechnology Can Help Achieve SDGs, Food Security- Experts. |
|
|
Oct 4, 2021 |
500 |
| Saudi Arabia's TRSDC teams up with Austrian biotech for sustainable food production. |
Arab News |
|
Oct 4, 2021 |
218 |
| Public urged: Take part in science-based discussions on biotech products' safety. |
|
|
Oct 3, 2021 |
615 |
| The significant influence of residual feed intake on flavor precursors and biomolecules in slow-growing Korat chicken meat. |
Poompramun, Chotima; Molee, Wittawat; Thumanu, Kanjana; Molee, Amonrat |
|
Oct 1, 2021 |
6791 |
| Emerging Military Technologies: Background and Issues for Congress. |
Sayler, Kelley M. |
Report |
Oct 1, 2021 |
16889 |
| Adaptive Biotechnologies launches closeSEQ assay reports. |
|
|
Sep 30, 2021 |
229 |
| Krystal Biotech receives approval from HREC in Australia for Phase 1 KB407 trial. |
|
|
Sep 29, 2021 |
320 |
| PharmaCyte Biotech announces encapsulation material does not alter cellular DNA. |
|
|
Sep 27, 2021 |
256 |
| US biotech billionaire to make COVID, cancer vaccines in S. Africa. |
|
|
Sep 24, 2021 |
377 |
| THE DEATH OF THE GENUS CLAIM. |
Karshtedt, Dmitry; Lemley, Mark A.; Seymore, Sean B. |
|
Sep 22, 2021 |
35229 |
| Persephone Biosciences Forges Collaboration with Janssen Biotech. |
|
|
Sep 21, 2021 |
252 |
| PDS Biotechnology achieves safety requirement milestone in VERSATILE-002 trial. |
|
|
Sep 20, 2021 |
345 |
| Edesa Biotech announces Phase 2 data of EB05 treatment of CVOID-19 patients. |
|
Clinical report |
Sep 20, 2021 |
380 |
| Adaptive Biotechnologies to present new COVID-19 data from immune platform. |
|
|
Sep 16, 2021 |
269 |
| PharmaCyte Biotech announces first test results of CypCaps clinical trial. |
|
|
Sep 16, 2021 |
168 |
| Saudi Arabia set to be 'regional hub' in biotechnology. |
Rashid Hassan |
|
Sep 15, 2021 |
726 |
| PDS Biotechnology reports inducement grant under Nasdaq listing rule. |
|
|
Sep 15, 2021 |
169 |
| Legend Biotech Begins Phase 1 Clinical Trial in the US to Evaluate Investigational Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma. |
|
|
Sep 13, 2021 |
382 |
| Purple Biotech to present overview of ongoing Phase 1b/2 trial of CM24. |
|
|
Sep 13, 2021 |
378 |
| Legend Biotech starts U.S. trial to evaluate LB1901, CAR-T, therapy for CTCL. |
|
|
Sep 13, 2021 |
213 |
| Boehringer Ingelheim partners with Twist Bioscience for multiple antibody research programmes. |
|
|
Sep 10, 2021 |
183 |
| Boehringer Ingelheim partners with Twist Bioscience for multiple antibody research programmes. |
|
|
Sep 10, 2021 |
182 |
| Sinovac Biotech announces new research on CoronaVac third dose. |
|
|
Sep 9, 2021 |
196 |
| Trinity Biotech reports Q2 adjusted EPS 20.3c vs. 1c last year. |
|
Financial report |
Sep 9, 2021 |
260 |
| Riyadh to host global summit on medical biotechnology in September. |
Rashid Hassan |
|
Sep 1, 2021 |
434 |
| PharmaCyte Biotech announces CypCaps remains stable, active at 18 months. |
|
|
Aug 31, 2021 |
153 |
| Saudi Biotech Center to improve the health of an oil-dependent economy. |
Arab News |
|
Aug 26, 2021 |
694 |
| Vertex Pharmaceuticals, Arbr Biotechnologies establish new collaboration. |
|
|
Aug 24, 2021 |
176 |
| Vir Biotechnology announces first marketing authorization for sotrovimab. |
|
|
Aug 23, 2021 |
287 |
| Alligator Bioscience and Orion Corporation sign research collaboration and license agreement. |
|
|
Aug 19, 2021 |
187 |
| Alligator Bioscience and Orion Corporation sign research collaboration and license agreement. |
|
|
Aug 19, 2021 |
188 |
| Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
169 |
| Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
167 |
| Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
168 |
| PBS Biotech Raises USD 10m to Provide Scale-Up Manufacturing Solutions for Cell Therapies. |
|
|
Aug 16, 2021 |
354 |
| Brickell Biotech announce final patient completed in Phase 3 Cardigan II study. |
|
|
Aug 16, 2021 |
167 |
| Fortress Biotech reports Q2 EPS (4c), consensus (12c). |
|
Financial report |
Aug 16, 2021 |
168 |
| Biotech firm raises PS7.5m after float. |
|
|
Aug 14, 2021 |
226 |
| Globe Biotech hopes for Bangavax human trials September. |
|
|
Aug 13, 2021 |
549 |
| PharmaCyte Biotech concludes USD15m public offering. |
|
|
Aug 13, 2021 |
156 |
| Evaxion Biotech reports Q2 EPS(36c) , consensus (29c). |
|
Financial report |
Aug 12, 2021 |
200 |
| PDS Biotechnology reports Q2 EPS (3c), consensus (17c). |
|
Financial report |
Aug 12, 2021 |
177 |
| Portage Biotech issues letter to shareholders. |
|
|
Aug 12, 2021 |
300 |
| PharmaCyte Biotech expects USD15m from public offering and uplists to NASDAQ. |
|
|
Aug 11, 2021 |
247 |
| PharmaCyte Biotech expects USD15m from public offering and uplists to NASDAQ. |
|
|
Aug 11, 2021 |
248 |
| Unity Biotechnology reports Q2 EPS (32c), consensus (31c). |
|
Financial report |
Aug 10, 2021 |
220 |
| Portage Biotech doses first patient in IMP-MEL study of PORT-2. |
|
|
Aug 5, 2021 |
200 |
| Purple Biotech reports 1H EPS (59c) vs. ($4.63) last year. |
|
Clinical report |
Aug 5, 2021 |
229 |
| Adverum Biotechnologies reports Q2 EPS (45c), consensus (38c). |
|
Financial report |
Aug 5, 2021 |
243 |
| Vir Biotechnology reports Q2 EPS 46c, consensus (48c). |
|
Financial report |
Aug 5, 2021 |
201 |
| Castle Biosciences Collaborates with the Melanoma Research Foundation. |
|
|
Aug 4, 2021 |
589 |
| PharmaCyte Biotech to upgrade to the Nasdaq Capital Market and announces upcoming public offering. |
|
|
Aug 3, 2021 |
217 |
| PharmaCyte Biotech to upgrade to the Nasdaq Capital Market and announces upcoming public offering. |
|
|
Aug 3, 2021 |
216 |
| Dhaka University team wins 1st biotech quiz competition. |
|
|
Aug 2, 2021 |
201 |
| Castle Biosciences collaborates with the Melanoma Research Foundation. |
|
|
Aug 2, 2021 |
180 |
| SaNOtize Inks Agreement with Indian Biotech Glenmark to Commercialize Nitric Oxide Nasal Spray for COVID-19 Treatment in India and other Asian Markets. |
|
|
Aug 2, 2021 |
476 |
| SANOTIZE INKS AGREEMENT WITH INDIAN BIOTECH GLENMARK. |
|
|
Aug 1, 2021 |
544 |
| PSU Outperforms PC in Sanitary Biotech Sight Gauge: Manufacturer of single-use systems for biotech applications opts for PSU over PC for improved heat and chemical resistance. |
Sherman, Lilli Manolis |
|
Aug 1, 2021 |
553 |
| The Bioeconomy: A Primer. |
Gallo, Marcy E. |
|
Aug 1, 2021 |
13348 |
| Portage Biotech reports 2021 EPS ($1.35) vs. (49c) last year. |
|
Financial report |
Jul 28, 2021 |
153 |
| Qorvo Biotechnologies Omnia SARS-CoV-2 antigen test platform complete milestone. |
|
|
Jul 28, 2021 |
223 |
| Protagonist Therapeutics announces amendment of agreement with Janssen Biotech. |
|
|
Jul 28, 2021 |
312 |
| Aurion Biotech trial shows IOTA cell therapy can restore vision to patients with blindness resulting from corneal endothelial disease. |
|
|
Jul 26, 2021 |
286 |
| Aurion Biotech Posts Preliminary Findings from IOTA Cell Therapy Trial. |
|
|
Jul 26, 2021 |
415 |
| Acticor Biotech Completes Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study. |
|
Clinical report |
Jul 23, 2021 |
449 |
| Unity Biotechnology to host investor call on Phase 1 trial of UBX1325. |
|
|
Jul 23, 2021 |
162 |
| Lixte Biotechnology comment on preclinical research on LB-100, dwarfism. |
|
|
Jul 22, 2021 |
243 |
| Adverum Biotechnologies no longer plans future development for DME in INFINITY. |
|
|
Jul 22, 2021 |
293 |
| NG Biotech unveils COVID-19 antigen self-test Ninonasal for detection of Delta and Epsilon variants across Europe. |
|
|
Jul 19, 2021 |
178 |
| NG Biotech unveils COVID-19 antigen self-test Ninonasal for detection of Delta and Epsilon variants across Europe. |
|
|
Jul 19, 2021 |
177 |
| GSK To Create Up To 5,000 Jobs As It Plans Huge Biotech Centre. |
|
|
Jul 17, 2021 |
346 |
| Trinity Biotech preparing for automated manufacture of TrinScreen HIV. |
|
|
Jul 16, 2021 |
233 |
| Trinity Biotech will not devote additional investment to UniGold SARS-CoV-2 test. |
|
|
Jul 16, 2021 |
233 |
| Vir Biotechnology initiates Phase 2 clinical trial evaluating VIR-2218, VIR-3434. |
|
|
Jul 15, 2021 |
178 |
| AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
194 |
| AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
195 |
| Sana Biotechnology to develop manufacturing facility in Fremont, CA. |
|
|
Jul 14, 2021 |
198 |
| Moleculin Biotech receives approval for amendment in Annamycin trial. |
|
|
Jul 13, 2021 |
176 |
| Yield10 Bioscience begins 2021 field test, seed scale up program. |
|
|
Jul 13, 2021 |
535 |
| Lixte Biotechnology comments on outside research on LB-100's PP2A inhibition. |
|
|
Jul 13, 2021 |
273 |
| Atlas Biotechnologies announces launch of Atlas Thrive. |
|
|
Jul 12, 2021 |
167 |
| I-Mab signs two new collaborations with Immorna, neoX Biotech. |
|
|
Jul 9, 2021 |
213 |
| Evaxion Biotech reports data from Phase 1/2a trials of EVX-01, EVX-02. |
|
|
Jul 8, 2021 |
498 |
| NABDA Sensitises FCCPC On Advances In Modern Biotechnology. |
|
|
Jul 8, 2021 |
665 |
| Globe Biotech workers assaulted while catching monkeys for vaccine trial. |
|
|
Jul 4, 2021 |
296 |
| Acticor Biotech Completes Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study. |
|
|
Jul 1, 2021 |
468 |
| Catalyst Biosciences to host R&D day on CB 4332, complement programs. |
|
|
Jul 1, 2021 |
300 |
| Krystal Biotech gives update on trial evaluating topical KB105 for ichthyosis. |
|
|
Jul 1, 2021 |
230 |
| Happiness Biotech enters securities purchase agreement for registered direct placement of USD 2.16m to strategic investors. |
|
|
Jun 30, 2021 |
164 |
| Happiness Biotech enters securities purchase agreement for registered direct placement of USD 2.16m to strategic investors. |
|
|
Jun 30, 2021 |
162 |
| Vir Biotechnology presents clinical data from trials of VIR-2218, VIR-3434. |
|
|
Jun 25, 2021 |
732 |
